Novartis Canada is pleased to announce that Scemblix® (asciminib) is one of the first therapies to be prioritized for public reimbursement under Ontario’s new ...

Bangladesh has nearly 4.96 million internally displaced people (IDPs) uprooted by floods, cyclones, river erosion and other natural hazards, according to the first nationwide estimate released on ...

Objective To assess the feasibility of conducting a cluster randomised controlled trial comparing the effects of Advanced Trauma Life Support (ATLS) and Primary Trauma Care (PTC) with standard care on ...